Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s share price traded down 4.4% during mid-day trading on Wednesday . The company traded as low as $2.25 and last traded at $2.28. 254,887 shares changed hands during trading, a decline of 95% from the average session volume of 4,782,219 shares. The stock had previously closed at $2.38.
Analyst Ratings Changes
Several research firms have recently commented on AGL. Needham & Company LLC reaffirmed a "hold" rating on shares of Agilon Health in a research note on Friday, March 21st. Barclays upped their price objective on Agilon Health from $2.00 to $3.00 and gave the company an "underweight" rating in a research report on Thursday, May 8th. TD Cowen upped their price target on shares of Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a report on Tuesday, April 15th. Cowen reaffirmed a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Finally, JMP Securities reissued a "market perform" rating on shares of Agilon Health in a research report on Monday, April 28th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, Agilon Health presently has an average rating of "Hold" and a consensus price target of $4.79.
Read Our Latest Research Report on AGL
Agilon Health Stock Up 0.3%
The business has a 50-day moving average of $2.60 and a 200-day moving average of $3.21. The stock has a market cap of $991.82 million, a price-to-earnings ratio of -4.06 and a beta of 0.16.
Agilon Health (NYSE:AGL - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The firm's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.02) EPS. Equities analysts anticipate that Agilon Health, Inc. will post -0.59 earnings per share for the current year.
Institutional Investors Weigh In On Agilon Health
Institutional investors have recently made changes to their positions in the stock. Signaturefd LLC grew its holdings in shares of Agilon Health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after acquiring an additional 8,467 shares in the last quarter. Humankind Investments LLC acquired a new position in shares of Agilon Health in the fourth quarter valued at about $30,000. Raymond James Financial Inc. bought a new position in Agilon Health during the 4th quarter worth $33,000. Cerity Partners LLC acquired a new stake in Agilon Health during the fourth quarter worth about $34,000. Finally, Nisa Investment Advisors LLC increased its stake in Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock valued at $41,000 after acquiring an additional 6,783 shares during the last quarter.
Agilon Health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.